Description of Research Expertise:
I have an interest in collaborative research that involves examining the intersection of health policy and kidney disease. I am actively involved in promoting and conducting quality improvement and patient safety initiatives within our division.
Anushya Jeyabalan MD, Shivam Joshi MD, Ankur Shah DO, Blaise Abramovitz DO, Anubhav Kumar MD, Alan Wasserstein MD, Jordana Cohen MD MSCE, C. Michael Chaknos MD MSHP, Dan Negoianu MD: Improving CRRT Lifespan: A QI Initiative Department of Medicine Research Day, Perelman School of Medicine : 2018.
Anushya Jeyabalan MD, Shivam Joshi MD, Ankur Shah DO, Blaise Abramovitz DO, Anubhav Kumar MD, Alan Wasserstein MD, Jordana Cohen MD MSCE, C. Michael Chaknos MD MSHP, Dan Negoianu MD: Improving CRRT Lifespan: A QI Initiative Annual Meeting of the American Society of Nephrology, New Orleans, LA : 2017.
Tiffany Wong, MD, C. Michael Chaknos, MD: Improving the transition of care for dialysis patients between hospital discharge and return to the dialysis unit
National Kidney Foundation Spring Clinical Meeting, Orlando, FL : 2017.
Seshasai Rebecca Kurnik, Mitra Nandita, Chaknos C Michael, Li Jiaqi, Wirtalla Christopher, Negoianu Dan, Glickman Joel D, Dember Laura M: Factors Associated With Discontinuation of Home Hemodialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation 67 (4): 629-37,2016.
Knauf F, Chaknos CM, Berns JS, Perazella MA: Dabigatran and kidney disease: a bad combination Clin J Am Soc Nephrol 8 (9): 1591-7,2013.
Chaknos CM, Berns JB: Erythropoesis Stimulating Agents on Trial: Are Higher Dosages Causing Harm? American Journal of Kidney Diseases 61 (1): 6-8,2013.
Chaknos CM, Berns JS: Hypercalcemia CURRENT Essentials of Nephrology and Hypertension : 2012.
Chaknos CM, Berns JS: Initiating dialysis at the right time: Is the evidence IDEAL? Seminars in Dialysis 23 (6): 627-9,2010.